Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic variants in the VEGF pathway as prognostic factors in stages II and III colon cancer
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2017-12-28
DOI
10.1038/s41397-017-0009-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy
- (2017) Paola Ulivi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes
- (2017) Michael S. Lee et al. Journal of the National Comprehensive Cancer Network
- Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers
- (2017) Frank A. Sinicrope et al. JAMA Oncology
- CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
- (2016) Piero Dalerba et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)
- (2015) F. A. Sinicrope et al. CLINICAL CANCER RESEARCH
- Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients
- (2015) Rodrigo Dienstmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I–III Non–Small-Cell Lung Cancer
- (2015) Dylan M. Glubb et al. Journal of Thoracic Oncology
- Significant effect ofVEGFApolymorphisms on the clinical outcome of metastatic colorectal cancer patients treated with FOLFIRI-cetuximab
- (2015) Jérôme Rollin et al. PHARMACOGENOMICS
- Different treatment strategies and molecular features between right-sided and left-sided colon cancers
- (2015) Hong Shen WORLD JOURNAL OF GASTROENTEROLOGY
- Colorectal cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Clinical genotyping and efficacy outcomes: Exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer
- (2014) Celine Pallaud et al. LUNG CANCER
- Single-Nucleotide Polymorphisms in the Vascular Endothelial Growth Factor Pathway and Outcomes of Patients Treated with First-Line Cytotoxic Chemotherapy Combined with Bevacizumab for Advanced Colorectal Cancer
- (2014) Byeong Seok Sohn et al. ONCOLOGY
- Discovery and Functional Assessment of Gene Variants in the Vascular Endothelial Growth Factor Pathway
- (2013) Laia Paré-Brunet et al. HUMAN MUTATION
- Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy
- (2013) Frank A. Sinicrope et al. JOURNAL OF CLINICAL ONCOLOGY
- The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region
- (2013) Ana Sebio et al. Pharmacogenetics and Genomics
- Prognostic importance of VEGF-A haplotype combinations in a stage II colon cancer population
- (2012) Sanne Kjaer-Frifeldt et al. PHARMACOGENOMICS
- Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer
- (2011) Guanglong Dong et al. CANCER SCIENCE
- Cancer Dormancy: A Model of Early Dissemination and Late Cancer Recurrence
- (2011) D. Paez et al. CLINICAL CANCER RESEARCH
- Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2011) A. Gerger et al. CLINICAL CANCER RESEARCH
- Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer
- (2011) Gordon Hutchins et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular endothelial growth factor pathway
- (2010) Michael L. Maitland et al. Pharmacogenetics and Genomics
- Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer
- (2009) Georg Lurje et al. Pharmacogenetics and Genomics
- Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
- (2008) G. Lurje et al. ANNALS OF ONCOLOGY
- Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival
- (2008) Konstantinos Dassoulas et al. MOLECULAR CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now